Related Experiment Videos
Effects of GABA(A) compounds on mCPP drug discrimination in rats
Michael B Gatch1, Marianna E Jung, Cleatus J Wallis
1Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth 76107-2699, USA. mgatch@hsc.unt.edu
Life Sciences
|October 2, 2002
Summary
GABA(A) antagonists, like bicuculline, affect the mCPP drug
Area of Science:
- Neuroscience
- Pharmacology
- Behavioral Science
Background:
- The discriminative stimulus effects of drugs are crucial for understanding their mechanisms of action.
- Meta-chlorophenylpiperazine (mCPP) is a drug with complex neurochemical effects.
- The role of GABA(A) receptors and their interaction with mCPP's effects requires further investigation.
Purpose of the Study:
- To investigate the involvement of GABA(A) receptors in the discriminative stimulus effects of mCPP.
- To determine if benzodiazepine receptor ligands can substitute for or block mCPP's effects.
- To elucidate the relationship between GABA(A) antagonism and mCPP-induced behaviors.
Main Methods:
- Rats were trained to discriminate mCPP from saline using a two-lever operant task.
- The effects of GABA(A) antagonist bicuculline were assessed.
- Benzodiazepine receptor ligands, including antagonists and inverse agonists, were tested for substitution and blockade effects.
Main Results:
- Bicuculline partially substituted for mCPP without altering response rates.
- Benzodiazepine antagonists and inverse agonists failed to substitute for mCPP.
- Neither flumazenil nor Ro 15-4513 blocked the mCPP discriminative stimulus.
- Ro 15-4513 decreased responding, while flumazenil slightly increased response rates.
Conclusions:
- GABA(A) antagonists modulate the discriminative stimulus effects of mCPP.
- These modulatory effects are not mediated through the benzodiazepine binding site.
- The findings suggest a complex interaction between GABAergic systems and mCPP's central effects.